Kondo K, Otake K, Iwasaki Y, Oiso Y, Takatsuki K
First Department of Internal Medicine, Nagoya University School of Medicine, Japan.
Nihon Naibunpi Gakkai Zasshi. 1989 May 20;65(5):537-48. doi: 10.1507/endocrine1927.65.5_537.
The concentration of unextracted urinary arginine vasopressin (UAVP) was directly measured by high-sensitive radioimmunoassay (AVP-RIA Kit, Mitsubishi Petrochemical Co., Ltd.). Urine was diluted to eliminate interference of nonspecific substance without prior extraction. When urine aliquots were diluted in 4 to 32 fold in assay buffer, the relationship between UAVP concentration and dilution ratio corresponded exactly in a linear regression line. The elution pattern on Sephadex G-25 of UAVP immunoreactivity was identical with that of synthesized AVP. The AVP concentration in unextracted urine was not significantly different from that of extracted urine by Sep-Pak C18 column (Water Associates, Milford MA). The mean recovery of added AVP to urine specimens was 101.1 +/- 9.8% (mean +/- SD). The immunoreactivity of UAVP was not modified by either albuminuria (50 and 100 mg/dl) or glycosuria (1000 g/dl). Mean coefficients of variance between-assay and within-assay were 8.3% and 6.6% respectively. In normal subjects (n = 28), significant correlation was observed between UAVP concentration and simultaneously measured plasma AVP (r = 0.701, p less than 0.001). Moreover, AVP concentration in random urine was significantly correlated with AVP excretion in 24 hr-urine (r = 0.703, p less than 0.05, n = 9), and this suggested that random UAVP concentration may indicate daily UAVP secretion. In normal subjects, AVP concentration in random urine was widely scattered from 9.2 to 470.6 pg/mg Cr (89.5 +/- 76.4 pg/mg Cr, n = 211). In patients with diabetes insipidus (DI), UAVP concentration (1.6 to 13.0 pg/mg Cr, 6.94 +/- 2.77 pg/mg Cr, n = 25) was significantly lower (p less than 0.001) than that of normal subjects. UAVP concentration in a patient with primary polydipsia (43.2 pg/mg Cr) was not similar to that of ID but to that of normal subjects. UAVP concentration in 2 patients with SIADH was not more than that of normal subjects, indicating that random UAVP concentration is not suitable for detecting inappropriate AVP secretion. In this study, it is suggested that patients of random UAVP concentration below 13.0 pg/mg Cr should be recommended other intensive examination to diagnose DI, even though 2 normal subjects (0.9%) were incorrectly estimated as DI. In conclusion, radioimmunoassay of AVP in unextracted random urine is easy to sample and assay, and useful in screening polyuric patients.
采用高灵敏度放射免疫分析法(AVP - RIA试剂盒,三菱石化有限公司)直接测定未提取的尿精氨酸加压素(UAVP)浓度。尿液无需预先提取,直接进行稀释以消除非特异性物质的干扰。当尿液等分试样在测定缓冲液中稀释4至32倍时,UAVP浓度与稀释倍数之间的关系在一条线性回归线上精确对应。UAVP免疫反应性在Sephadex G - 25上的洗脱模式与合成的AVP相同。未提取尿液中的AVP浓度与通过Sep - Pak C18柱(Water Associates,米尔福德,马萨诸塞州)提取的尿液中的AVP浓度无显著差异。向尿液标本中添加AVP后的平均回收率为101.1±9.8%(平均值±标准差)。蛋白尿(50和100mg/dl)或糖尿(1000mg/dl)均未改变UAVP的免疫反应性。批间和批内变异系数的平均值分别为8.3%和6.6%。在正常受试者(n = 28)中,观察到UAVP浓度与同时测定的血浆AVP之间存在显著相关性(r = 0.701,p<0.001)。此外,随机尿中的AVP浓度与24小时尿中的AVP排泄量显著相关(r = 0.703,p<0.05,n = 9),这表明随机UAVP浓度可能指示每日UAVP分泌情况。在正常受试者中,随机尿中的AVP浓度广泛分布于9.2至470.6pg/mg Cr(89.5±76.4pg/mg Cr,n = 211)。在尿崩症(DI)患者中,UAVP浓度(1.6至13.0pg/mg Cr,6.94±2.77pg/mg Cr,n = 25)显著低于正常受试者(p<0.001)。一例原发性烦渴患者的UAVP浓度(43.2pg/mg Cr)与DI患者不同,而与正常受试者相似。2例抗利尿激素分泌异常综合征(SIADH)患者的UAVP浓度不高于正常受试者,这表明随机UAVP浓度不适合检测不适当的AVP分泌。在本研究中,建议随机UAVP浓度低于13.0pg/mg Cr的患者应推荐进行其他强化检查以诊断DI,尽管有2名正常受试者(0.9%)被错误地估计为DI。总之,未提取的随机尿中AVP的放射免疫分析易于采样和检测,对多尿患者的筛查有用。